what's trending

5 most popular innovation stories in Houston this week

A new energy transition leader, a Q&A with a DEI founder, and innovators to know are among this week's top stories. Photo by Zview/Getty Images

Editor's note:Another week has come and gone, and it's time to round up the top headlines from the past few days. Trending Houston tech and startup news on InnovationMap included innovators to know, fastest growing Houston tech companies, a new energy transition leader, and more.

3 Houston innovators to know this week

This week's roundup of Houston innovators includes Aaron Knape of sEATz, Ivery Boston III of Houston Exponential, and Jesse Martinez of the LatinX Startup Alliance. Courtesy photos

In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from sportstech to startup-focused nonprofit work — recently making headlines in Houston innovation. Click here to read more.

International energy conference names 12 Houston companies to pitch at inaugural innovation track

Twelve Houston startups will pitch at the World Petroleum Congress, which will be hosted in Houston this year. Photo via Getty Images

A dozen Houston companies will take the stage next month for a pitch competition during the World Petroleum Congress at the George R. Brown Convention Center.

In all, 32 innovators have been selected to make presentations at the World Petroleum Congress' first-ever Innovation Zone. Presented by ConocoPhillips, the Innovation Zone will let startups showcase their solutions to challenges facing the energy sector. The winner of the pitch competition will receive the inaugural Energy Innovator Award. Click here to continue reading.

Houston native brings LatinX startup support to the Ion with HQ move

Jesse Martinez, founder of the LatinX Startup Alliance, joins InnovationMap for a Q&A on why he's relocating his nonprofit to Houston. Photo courtesy of LSA

Jesse Martinez was working in Silicon Valley before it was Silicon Valley. He took his years of experience within that tech ecosystem and launched the LatinX Startup Alliance to support his fellow Hispanic entrepreneurs — and now he's bringing that support to his hometown.

The LatinX Startup Alliance will move its headquarters into The Ion in 2022, Martinez tells InnovationMap. He's excited to finally make his professional return to Houston and to help support the diverse ecosystem — one that has been created with diversity at the forefront, unlike Silicon Valley and other coastal tech hubs.

"We're on the ground floor. We're helping to build that foundation. It's not an afterthought. It's not something that now we're trying to go back and think of diversity," Martinez tells InnovationMap. "I think that's the beautiful thing about Houston and everyone that I've met is that it's been so diverse and inclusive. That spirit is already there. So, how do we just maximize that?"

Martinez joined InnovationMap for a Q&A about the new HQ announcement and what he's excited about in terms of DEI in Houston's tech scene. Click here to continue reading.

Greater Houston Partnership names former BP exec to lead energy transition

The former BP executive will lead Houston's role in the energy transition as the executive director of the Houston Energy Transition Initiative, a brand new position at the Greater Houston Partnership. Photo courtesy of GHP

Jane Stricker, a longtime Houston-based executive at oil and gas giant BP, has been tapped to lead the Greater Houston Partnership's new initiative designed to boost the Bayou City's profile in the shift toward low-carbon energy.

The partnership announced Stricker's hiring November 11. She'll join the organization effective January 1 as executive director of the Houston Energy Transition Initiative (HETI) and senior vice president of energy transition.

The Greater Houston Partnership unveiled HETI in June. As the partnership explained then, HETI "aims to drive sustainable and equitable economic growth in the Greater Houston region through a portfolio of technology, policy, and market initiatives that scale and export solutions for realizing a low-carbon energy world." Click here to continue reading.

3 Houston companies make Deloitte's fastest-growing tech list

Three Houston tech companies are seeing big business growth, according to Deloitte's report. Graphic via Deloitte

Three Houston companies have earned spots on this year's edition of the North American Technology Fast 500.

The North America Technology Fast 500, sponsored by professional services firm Deloitte, is an annual ranking of the fastest-growing tech, media, telecom, life sciences, and energy tech companies in North America.

"The Houston companies on this year's Fast 500 list are transforming the way our city does business by combining technological innovation with entrepreneurial spirit," Amy Chronis, Houston managing partner at Deloitte, says in a news release. "I'm inspired by the ways these organizations have succeeded amid unprecedented times, and I look forward to seeing their progress in 2022."

The top-ranked company is Irvine, California-based medical device company Axonics, whose revenue soared 87,037 percent from 2017 to 2020. The top-ranked Texas company is Austin-based Shipwell, where revenue climbed 32,670 percent from 2017 to 2020. Shipwell provides a shipment-tracking platform. Overall, 5 percent of the Fast 500 companies are based in Texas. Click here to continue reading.

Trending News

 
 

Promoted

A research team housed out of the newly launched Rice Biotech Launch Pad received funding to scale tech that could slash cancer deaths in half. Photo via Rice University

A research funding agency has deployed capital into a team at Rice University that's working to develop a technology that could cut cancer-related deaths in half.

Rice researchers received $45 million from the National Institutes of Health's Advanced Research Projects Agency for Health, or ARPA-H, to scale up development of a sense-and-respond implant technology. Rice bioengineer Omid Veiseh leads the team developing the technology as principal investigator.

“Instead of tethering patients to hospital beds, IV bags and external monitors, we’ll use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time,” he says in a news release. “This kind of ‘closed-loop therapy’ has been used for managing diabetes, where you have a glucose monitor that continuously talks to an insulin pump. But for cancer immunotherapy, it’s revolutionary.”

Joining Veiseh on the 19-person research project named THOR, which stands for “targeted hybrid oncotherapeutic regulation,” is Amir Jazaeri, co-PI and professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center. The device they are developing is called HAMMR, or hybrid advanced molecular manufacturing regulator.

“Cancer cells are continually evolving and adapting to therapy. However, currently available diagnostic tools, including radiologic tests, blood assays and biopsies, provide very infrequent and limited snapshots of this dynamic process," Jazaeri adds. "As a result, today’s therapies treat cancer as if it were a static disease. We believe THOR could transform the status quo by providing real-time data from the tumor environment that can in turn guide more effective and tumor-informed novel therapies.”

With a national team of engineers, physicians, and experts across synthetic biology, materials science, immunology, oncology, and more, the team will receive its funding through the Rice Biotech Launch Pad, a newly launched initiative led by Veiseh that exists to help life-saving medical innovation scale quickly.

"Rice is proud to be the recipient of the second major funding award from the ARPA-H, a new funding agency established last year to support research that catalyzes health breakthroughs," Rice President Reginald DesRoches says. "The research Rice bioengineer Omid Veiseh is doing in leading this team is truly groundbreaking and could potentially save hundreds of thousands of lives each year. This is the type of research that makes a significant impact on the world.”

The initial focus of the technology will be on ovarian cancer, and this funding agreement includes a first-phase clinical trial of HAMMR for the treatment of recurrent ovarian cancer that's expected to take place in the fourth year of THOR’s multi-year project.

“The technology is broadly applicable for peritoneal cancers that affect the pancreas, liver, lungs and other organs,” Veiseh says. “The first clinical trial will focus on refractory recurrent ovarian cancer, and the benefit of that is that we have an ongoing trial for ovarian cancer with our encapsulated cytokine ‘drug factory’ technology. We'll be able to build on that experience. We have already demonstrated a unique model to go from concept to clinical trial within five years, and HAMMR is the next iteration of that approach.”

Trending News

 
 

Promoted